Paper20175879
Reduced skin homing by functional Treg in vitiligo.
Klarquist J and 9 others. Pigment Cell Melanoma Res, 2010. Cited by 149 papers, by iCite.
Cite this record
ConductScience Library. Reduced skin homing by functional Treg in vitiligo. Papers, record 20175879. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20175879
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Skin | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Vitiligo | Major topic |
| Adolescent | |
| Adult | |
| Antigens, Differentiation, T-Lymphocyte | |
| Female | |
| Humans | |
| Male | |
| Membrane Glycoproteins | |
| Middle Aged | |
| Receptors, CCR4 | |
| Receptors, CCR5 | |
| Receptors, CCR8 | |
| Young Adult |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F32 NS073366 | NINDS NIH HHS | United States | F32NS073366 | PubMed | NIH RePORTER |
| R01 AR057643 | NIAMS NIH HHS | United States | R01AR057643 | PubMed and NIH | NIH RePORTER |
| R00 NS082381 | NINDS NIH HHS | United States | R00NS082381 | PubMed | NIH RePORTER |
| R01 AR047951 | NIAMS NIH HHS | United States | R01AR047951 | PubMed and NIH | NIH RePORTER |
| K99 NS082381 | NINDS NIH HHS | United States | K99NS082381 | PubMed | NIH RePORTER |
| R01 CA104947 | NCI NIH HHS | United States | R01CA104947 | PubMed and NIH | NIH RePORTER |
| R01 CA109536 | NCI NIH HHS | United States | R01CA109536 | PubMed and NIH | NIH RePORTER |
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19426629 | Familial coexisting and colocalized psoriasis and vitiligo responding to alefacept. | J Cutan Med Surg | 2009 | https://conductscience.org/library/papers/19426629 | PubMed |
| 2 | 17315189 | Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. | Int J Cancer | 2007 | https://conductscience.org/library/papers/17315189 | PubMed |
| 3 | 17031470 | Induction and maintenance of self tolerance: the role of CD4+CD25+ regulatory T cells. | Arch Immunol Ther Exp (Warsz) | 2006 | https://conductscience.org/library/papers/17031470 | PubMed |
| 4 | 7706738 | CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. | J Immunol | 1995 | https://conductscience.org/library/papers/7706738 | PubMed |
| 5 | 16818373 | T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity. | Int Rev Immunol | 2006 | https://conductscience.org/library/papers/16818373 | PubMed |
| 6 | 12778466 | Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. | Eur J Immunol | 2003 | https://conductscience.org/library/papers/12778466 | PubMed |
| 7 | 18337834 | HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. | J Invest Dermatol | 2008 | https://conductscience.org/library/papers/18337834 | PubMed |
| 8 | 16920575 | Therapeutic implications of autoimmune vitiligo T cells. | Autoimmun Rev | 2006 | https://conductscience.org/library/papers/16920575 | PubMed |
| 9 | 17210720 | Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. | Cancer Res | 2007 | https://conductscience.org/library/papers/17210720 | PubMed |
| 10 | 15234546 | Interferon-gamma is an autocrine mediator for dendritic cell maturation. | Immunol Lett | 2004 | https://conductscience.org/library/papers/15234546 | PubMed |
| 11 | 19648274 | IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. | J Immunol | 2009 | https://conductscience.org/library/papers/19648274 | PubMed |
| 12 | 17478450 | Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses. | J Histochem Cytochem | 2007 | https://conductscience.org/library/papers/17478450 | PubMed |
| 13 | 11286727 | A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. | Trends Immunol | 2001 | https://conductscience.org/library/papers/11286727 | PubMed |
| 14 | 7684427 | Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. | J Invest Dermatol | 1993 | https://conductscience.org/library/papers/7684427 | PubMed |
| 15 | 19514119 | Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. | Cancer Sci | 2009 | https://conductscience.org/library/papers/19514119 | PubMed |
| 16 | 18388146 | Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. | Rheumatology (Oxford) | 2008 | https://conductscience.org/library/papers/18388146 | PubMed |
| 17 | 9743539 | High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. | J Exp Med | 1998 | https://conductscience.org/library/papers/9743539 | PubMed |
| 18 | 17346153 | The Janus face of CD4+CD25+ regulatory T cells in cancer and autoimmunity. | Curr Med Chem | 2007 | https://conductscience.org/library/papers/17346153 | PubMed |
| 19 | 11839572 | Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells. | Am J Pathol | 2002 | https://conductscience.org/library/papers/11839572 | PubMed |
| 20 | 15336780 | Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. | Hum Immunol | 2004 | https://conductscience.org/library/papers/15336780 | PubMed |
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 149 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42799418 | Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42799418 | PubMed |
| 42688560 | Decoding Treg diversity and dysfunction to advance Treg-based therapies in autoimmune and inflammatory diseases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42688560 | PubMed |
| 42645912 | Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes. | J Pers Med | 2026 | https://conductscience.org/library/papers/42645912 | PubMed |
| 42441234 | Dysregulation of T Helper 17 Cell Pathway In Vitiligo. | Indian J Dermatol | 2026 | https://conductscience.org/library/papers/42441234 | PubMed |
| 42105025 | Vitiligo as a Failure of Immune Resolution and Tissue Regeneration: From Stress Signals to Targeted Immune Modulation. | Clin Rev Allergy Immunol | 2026 | https://conductscience.org/library/papers/42105025 | PubMed |
| 41482575 | The immunology of vitiligo. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/41482575 | PubMed |
| 41370369 | Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin. | Sci Adv | 2025 | https://conductscience.org/library/papers/41370369 | PubMed |
| 41327822 | Pathogenesis of Vitiligo: Integrating Immune and Non-Immune Cell Crosstalk. | J Dermatol | 2026 | https://conductscience.org/library/papers/41327822 | PubMed |
| 41169396 | Innate immune activation in vitiligo: mechanisms and pathophysiological implications. | Front Immunol | 2025 | https://conductscience.org/library/papers/41169396 | PubMed |
| 40933988 | Tissue-specific roles of regulatory T cells: mechanisms of suppression and beyond along with emerging therapeutic insights in autoimmune indications. | Front Immunol | 2025 | https://conductscience.org/library/papers/40933988 | PubMed |
| 40704943 | Deciphering Depigmentation: Mouse Models for Vitiligo Research. | J Invest Dermatol | 2025 | https://conductscience.org/library/papers/40704943 | PubMed |
| 40660423 | Regulatory T Cell Dysregulation in Vitiligo: A Meta-Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives. | Int J Dermatol | 2025 | https://conductscience.org/library/papers/40660423 | PubMed |
| 40355834 | Chromatin accessibility profiling of Treg cells in acute urticaria. | Epigenetics | 2025 | https://conductscience.org/library/papers/40355834 | PubMed |
| 39901288 | Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases. | Biomark Res | 2025 | https://conductscience.org/library/papers/39901288 | PubMed |
| 39274437 | Vitiligo: From Pathogenesis to Treatment. | J Clin Med | 2024 | https://conductscience.org/library/papers/39274437 | PubMed |
| 38918590 | Topical application of simvastatin acid sodium salt and atorvastatin calcium salt in vitiligo patients. Results of the randomized, double-blind EVRAAS pilot study. | Sci Rep | 2024 | https://conductscience.org/library/papers/38918590 | PubMed |
| 38839628 | The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review. | Inflamm Res | 2024 | https://conductscience.org/library/papers/38839628 | PubMed |
| 38392077 | Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center. | Curr Oncol | 2024 | https://conductscience.org/library/papers/38392077 | PubMed |
| 38077333 | Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo. | Front Immunol | 2023 | https://conductscience.org/library/papers/38077333 | PubMed |
| 37867188 | Regulatory T cells in skin regeneration and wound healing. | Mil Med Res | 2023 | https://conductscience.org/library/papers/37867188 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20175879
GET https://conductscience.org/api/papers/v1/20175879/references?page=2